Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ChiCTR |
Last refreshed on:
|
5 May 2019 |
Main ID: |
ChiCTR1900022715 |
Date of registration:
|
2019-04-23 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Accurate treatment under the multidisciplinary cooperative diagnosis and treatment model of Parkinson's disease
|
Scientific title:
|
Accurate treatment under the multidisciplinary cooperative diagnosis and treatment model of Parkinson's disease |
Date of first enrolment:
|
2019-05-01 |
Target sample size:
|
Anteversion group:40;Balance dysfunction group:40;Gait abnormality group:40; |
Recruitment status: |
Recruiting |
URL:
|
http://www.chictr.org.cn/showproj.aspx?proj=35352 |
Study type:
|
Observational study |
Study design:
|
Factorial
|
Phase:
|
N/A
|
|
Countries of recruitment
|
China
| | | | | | | |
Contacts
|
Name:
|
Siquan Liang
|
Address:
|
6 Jizhao Road, Jinnan District, Tianjin
|
Telephone:
|
+86 13114862005 |
Email:
|
liangsiquan@163.com |
Affiliation:
|
Tianjin Huanhu Hospital |
|
Name:
|
Haitao Li
|
Address:
|
6 Jizhao Road, Jinnan District, Tianjin
|
Telephone:
|
+86 18622115251 |
Email:
|
sdzclht@163.com |
Affiliation:
|
Tianjin Huanhu Hospital |
| |
Key inclusion & exclusion criteria
|
Inclusion criteria: 1 Conforms to the PD PD of the UK PD or the primary diagnostic criteria of PD in China.
2 Course > 5 years of diagnosis of primary PD patients.
3 Levodopa impact test improved > 30%.
4 Aged = 75 years.
5 The efficacy of the drug is significantly reduced or there is motor fluctuation or dyskinesia, which affects the quality of life of patients.
6 Severity of illness: "off" period Hoehn-Yahr (H-Y) 2. 5 ~ 4 period.
7 Reasonable postoperative expectation. 8 no surgical contraindications
Exclusion criteria: 1. Obvious cognitive dysfunctions;
2. Severe (refractory) depression, anxiety, schizophrenia and other mental illnesses;
3. Medical coexisting diseases affect surgery or survival.
Age minimum:
Age maximum:
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Parkinson's Disease
|
Intervention(s)
|
Anteversion group:DBS;Balance dysfunction group:DBS;Gait abnormality group:DBS;
|
Primary Outcome(s)
|
angle of anteversion;gait;stability;
|
Source(s) of Monetary Support
|
Tianjin Huanhu Hospital
|
Ethics review
|
Status: Approved
Approval date: 03/04/2019
Contact:
Ren Feng
+86 022 59065824
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|